Russell Garman is an associate in the New York office of Frommer Lawrence & Haug LLP. His practice focuses on developing and implementing life cycle management strategies for life science technologies, in particular pharmaceutical products. He guides clients on how to strengthen their patent portfolios and protect their inventions, as well as advises on how to market their products. He also works with clients in coordinating their intellectual property and regulatory strategies in order to meet both their immediate and long-term business objectives.
Dr. Garman has experience in preparing and prosecuting patent applications for life science technologies, such as pharmaceutical formulations, vaccines, gene therapy and gene expression, recombinant cell and protein therapy, immunotherapy, transgenic animals and plants, and food compositions. His practice extends to areas of biomedical and material engineering, including medical and physical therapy devices such as artificial joints and vascular and airway stents; compositions for bone restoration; and textiles. In addition, he performs due diligence, freedom-to-operate, and patentability studies on life science products.
Dr. Garman completed his B.S. with honors in Bioengineering, concentrating in Biomechanics, at Syracuse University. He then received his M.S. and Ph.D. in Biomedical Engineering at Stony Brook University, researching a novel physical stimulus to induce bone formation and prevent bone loss in osteoporotic skeletons. He received his J.D. from Fordham University Law School.